Baxter International

Does Cell Therapy Hold The Key To Treating Stroke?

Does Cell Therapy Hold The Key To Treating Stroke?

Seeking Alpha

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment

Forbes

Baxter posts lower earnings on acquisition-related expenses

Baxter posts lower earnings on acquisition-related expenses

Reuters

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy

Seeking Alpha

Halozyme Rallies On Success In Europe, US Next Target

Halozyme Rallies On Success In Europe, US Next Target

Seeking Alpha

Biogen, Baxter, Sanofi, Gilead Win EU Endorsements

Biogen, Baxter, Sanofi, Gilead Win EU Endorsements

Investors.com

Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech

Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech

Fierce Biotech

Baxter International Fourth Quarter 2012 Financial Results Conference Call

Baxter International Fourth Quarter 2012 Financial Results Conference Call

Yahoo/BusinessWire

Baxter Announces Phase III Data Evaluating Prophylaxis Treatment of FEIBA NF for Hemophilia Patients with Inhibitors

Baxter Announces Phase III Data Evaluating Prophylaxis Treatment of FEIBA NF for Hemophilia Patients with Inhibitors

Yahoo/BusinessWire

Submitted by admin on Wed, 11/28/2012 - 00:15

Baxter International is said to be in the hunt for a $4 billion acquisition of Swedish medical device company Gambro

Baxter International is said to be in the hunt for a $4 billion acquisition of Swedish medical device company Gambro

Mass Device